Bio-Raid
Wuhan
About Bio-Raid
Bio-Raid is a pharmaceutical company that specializes in CAR-T immune cell therapy research and development, pilot testing, and approval. Its core focus is on creating CAR-T treatments for hematological cancers, but it also works on CAR-T therapies for viral infectious disorders, solid tumors, general-purpose CAR-T, T cells, and stem cells.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $2.9M
- Last round: Series Unknown (Jan 2017)
- Website: bio-raid.com
- Phone: 027-5931-8269
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/bio-raid-175044 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.